Back to List View Graph View

Antigen

An antigen is a molecule, molecular structure, or molecular fragment that can be specifically recognized by components of the immune system, including antibodies, immunoglobulin M, B-cell receptors, and T-cell receptors.

Where the papers sit

9 papers from the last 6 months study antigen directly · updated from PubMed 17 Nov 2026

Study type 0 clinical trials · 2 human data · 7 preclinical

Themes one subject

Those 9 are all about one subject.

  • Vaccine Technology Development

    Vaccine design is expanding from antigen selection toward stability, structure-guided engineering, targeted delivery, and tissue-specific immune programming. Nanocarriers, mRNA-LNPs, adenoviral vectors, and APC targeting recur as routes to improve immunogenicity and delivery. Pathogen genomics and MOMP stability support antigen selection and deployable formulations, while biomolecule-detection platforms aid measurement. The work remains exploratory, with no single platform or disease dominating.

    9 papers

Papers

The 9 papers from the last 6 months that study antigen directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Vaccine Technology Development (9)
  1. A Multiformat Alginate Hydrogel Platform for Persistent Luminescence-Based Biomolecule Detection in Human Serum. ACS applied bio materials · 6 Nov 2026 PMID 42993017
  2. Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes. Journal of chemical information and modeling · 14 Sept 2026 PMID 42734515
  3. Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity. ACS nano · 8 Sept 2026 PMID 42708904
  4. Integrated genomic analysis of Salmonella Typhi from Pakistan: Antimicrobial resistance determinants, pangenome structure, and reverse vaccinology-driven vaccine target discovery. Functional & integrative genomics · 19 Aug 2026 PMID 42616173
  5. Stability of Chlamydia pecorum MOMP at 37 °C: suitability for use in delayed-release vaccine implants in koalas (Phascolarctos cinereus). Vaccine · 4 Aug 2026 PMID 42551398
  6. Advancements in Syphilis Vaccine Development. Sexually transmitted diseases · 1 Jul 2026 PMID 42383911
  7. Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379311
  8. Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines. Molecular therapy : the journal of the American Society of Gene Therapy · 27 Jun 2026 PMID 42363600
  9. Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International journal of nanomedicine · 18 Jun 2026 PMID 42311421

By study type

Human data, design not indexed (2)
  1. A Multiformat Alginate Hydrogel Platform for Persistent Luminescence-Based Biomolecule Detection in Human Serum. ACS applied bio materials · 6 Nov 2026 PMID 42993017
  2. Integrated genomic analysis of Salmonella Typhi from Pakistan: Antimicrobial resistance determinants, pangenome structure, and reverse vaccinology-driven vaccine target discovery. Functional & integrative genomics · 19 Aug 2026 PMID 42616173
Preclinical: animal, cell and lab studies (7)
  1. Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes. Journal of chemical information and modeling · 14 Sept 2026 PMID 42734515
  2. Phenylborate-Functionalized Nanocarriers Enable Lung-Tropic Protein Delivery and Reprogramming of Tissue-Resident Immunity. ACS nano · 8 Sept 2026 PMID 42708904
  3. Stability of Chlamydia pecorum MOMP at 37 °C: suitability for use in delayed-release vaccine implants in koalas (Phascolarctos cinereus). Vaccine · 4 Aug 2026 PMID 42551398
  4. Advancements in Syphilis Vaccine Development. Sexually transmitted diseases · 1 Jul 2026 PMID 42383911
  5. Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy. Journal of controlled release : official journal of the Controlled Release Society · 30 Jun 2026 PMID 42379311
  6. Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines. Molecular therapy : the journal of the American Society of Gene Therapy · 27 Jun 2026 PMID 42363600
  7. Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International journal of nanomedicine · 18 Jun 2026 PMID 42311421